Current treatments, which range from steroids to immunosuppressants and targeted biologics, often fail to control the disease. Some 10% to 15% of people with lupus die prematurely
<iframe src="https://hindustansphere.com/embed/cluster/dccafe800ecb2d63e30a76d08f0fb880ed722976" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="CAR-T trial deaths do not deter lupus patients hoping for a cure"></iframe>
Current treatments, which range from steroids to immunosuppressants and targeted biologics, often fail to control the disease. Some 10% to 15% of people with lupus die prematurely
